BioGaia AB (publ) (LON:0GTN)
99.83
-6.17 (-5.82%)
At close: Feb 12, 2026
BioGaia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,538 | 1,423 | 1,297 | 1,104 | 785.11 | |
Revenue Growth (YoY) | 8.12% | 9.74% | 17.44% | 40.61% | 5.09% |
Cost of Revenue | 409.59 | 391.98 | 346.32 | 302.03 | 202.16 |
Gross Profit | 1,129 | 1,031 | 950.19 | 801.93 | 582.95 |
Selling, General & Admin | 560.89 | 464.28 | 402.51 | 360.62 | 230.76 |
Research & Development | 115.72 | 105.95 | 106.78 | 106.81 | 105.47 |
Other Operating Expenses | 39.51 | - | - | - | 0 |
Operating Expenses | 716.12 | 570.23 | 509.28 | 467.42 | 336.23 |
Operating Income | 412.47 | 460.51 | 440.91 | 334.51 | 246.72 |
Interest Expense | -8.45 | -1.44 | -0.81 | -5.39 | -1.13 |
Interest & Investment Income | - | 39.37 | 41.53 | 7.96 | 0.11 |
Currency Exchange Gain (Loss) | - | 13.89 | 1.82 | 26.79 | 11.14 |
Other Non Operating Income (Expenses) | 17.2 | 0 | - | 3.56 | - |
EBT Excluding Unusual Items | 421.22 | 512.33 | 483.45 | 367.44 | 256.84 |
Merger & Restructuring Charges | - | - | - | - | -4.23 |
Impairment of Goodwill | - | -5.3 | - | - | - |
Asset Writedown | - | -45.85 | - | - | - |
Other Unusual Items | - | -13.37 | -14.62 | 80.17 | 0.1 |
Pretax Income | 421.22 | 447.82 | 468.83 | 447.61 | 252.71 |
Income Tax Expense | 88.46 | 96.43 | 103.48 | 73.84 | 56.44 |
Earnings From Continuing Operations | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income to Company | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income to Common | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income Growth | -5.30% | -3.82% | -2.25% | 90.44% | 9.20% |
Shares Outstanding (Basic) | 101 | 101 | 101 | 101 | 101 |
Shares Outstanding (Diluted) | 101 | 101 | 101 | 101 | 101 |
Shares Change (YoY) | 0.09% | 0.09% | - | - | 13.11% |
EPS (Basic) | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS (Diluted) | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS Growth | -5.38% | -3.91% | -2.22% | 90.72% | -3.64% |
Free Cash Flow | 303.04 | 359.46 | 377.4 | 301.03 | 215.5 |
Free Cash Flow Per Share | 3.00 | 3.56 | 3.74 | 2.98 | 2.13 |
Dividend Per Share | - | 1.950 | 1.900 | 1.450 | 0.730 |
Dividend Growth | - | 2.63% | 31.03% | 98.63% | 7.04% |
Gross Margin | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
Operating Margin | 26.82% | 32.37% | 34.01% | 30.30% | 31.42% |
Profit Margin | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
Free Cash Flow Margin | 19.70% | 25.27% | 29.11% | 27.27% | 27.45% |
EBITDA | 437.13 | 477.17 | 455.44 | 348.71 | 259.98 |
EBITDA Margin | 28.42% | 33.54% | 35.13% | 31.59% | 33.11% |
D&A For EBITDA | 24.67 | 16.66 | 14.53 | 14.2 | 13.25 |
EBIT | 412.47 | 460.51 | 440.91 | 334.51 | 246.72 |
EBIT Margin | 26.82% | 32.37% | 34.01% | 30.30% | 31.42% |
Effective Tax Rate | 21.00% | 21.53% | 22.07% | 16.50% | 22.33% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.